XBKK
AHC
Market cap63mUSD
Nov 12, Last price
14.20THB
Name
Aikchol Hospital PCL
Chart & performance
P/E
13.85
P/S
1.19
EPS
1.03
Div yield, %
4.44%
Shrs. gr., 5y
—
Rev. gr., 5y
4.81%
Revenues
1.79b
+2.09%
Net income
154m
+21.05%
CFO
215m
+13.84%
Dividend
Apr 30, 20260.52 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1978 and based in Chonburi, Thailand, Aikchol Hospital Public Company Limited is a healthcare provider operating under the Aikchol Hospital brand. The company offers a full spectrum of medical and nursing services, including disease prevention, treatment, health enhancement, and rehabilitation, supported by its 310-bed facility. Its patient base is diverse, serving private individuals, policyholders from insurance companies, employees of corporate clients, and those enrolled in social security programs.
Key people
Chairman of the Management Board · since 2025
Jakapan Bhongsatiern
Chief Executive Officer · since 2025
Sanit Chakrit
Managing Director of Medicine of Aikchol Hospital, Director · since 2014
Somphorn Phoemsuk
Managing Director of Management
Siriphot Manoch
Chief Strategy Officer · since 2023
Wilaliux Srisuwan
Company Secretary · since 2023
Sarayut Rueangsuwan
Director · since 2022
Chairman of the Board
Director
Oranut Wanit
Director · since 2011
Kritsada Banchuen
Independent Director
Thitawat Pothanant
Independent Director · since 2017
Kudun Sukhumananda
Independent Director · since 2019
Kitti Thoranin
Independent Director
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||